Figure 5.
Percentage of FEV1 value variation in each patient between pretreatment and after 3 months of treatment with benralizumab. The dotted line shows the mean of all patients.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.